These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 31613195)

  • 1. Positron Emission Tomography: Updates on Imaging of Addiction.
    Solingapuram Sai JKK; Hurley RA; Dodda M; Taber KH
    J Neuropsychiatry Clin Neurosci; 2019; 31(4):A6-288. PubMed ID: 31613195
    [No Abstract]   [Full Text] [Related]  

  • 2. Imaging neurotransmitter release by drugs of abuse.
    Martinez D; Narendran R
    Curr Top Behav Neurosci; 2010; 3():219-45. PubMed ID: 21161755
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nonhuman primate positron emission tomography neuroimaging in drug abuse research.
    Howell LL; Murnane KS
    J Pharmacol Exp Ther; 2011 May; 337(2):324-34. PubMed ID: 21317354
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Positron emission tomography molecular imaging of dopaminergic system in drug addiction.
    Hou H; Tian M; Zhang H
    Anat Rec (Hoboken); 2012 May; 295(5):722-33. PubMed ID: 22467195
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Brain dopaminergic system changes in drug addiction: a review of positron emission tomography findings.
    Hou H; Wang C; Jia S; Hu S; Tian M
    Neurosci Bull; 2014 Oct; 30(5):765-76. PubMed ID: 25260796
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Imaging the D3 dopamine receptor across behavioral and drug addictions: Positron emission tomography studies with [(11)C]-(+)-PHNO.
    Boileau I; Nakajima S; Payer D
    Eur Neuropsychopharmacol; 2015 Sep; 25(9):1410-20. PubMed ID: 26141509
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Positron emission tomography and single-photon emission computed tomography in substance abuse research.
    Volkow ND; Fowler JS; Wang GJ
    Semin Nucl Med; 2003 Apr; 33(2):114-28. PubMed ID: 12756644
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Imaging the neurochemistry of alcohol and substance abuse.
    Martinez D; Kim JH; Krystal J; Abi-Dargham A
    Neuroimaging Clin N Am; 2007 Nov; 17(4):539-55, x. PubMed ID: 17983969
    [TBL] [Abstract][Full Text] [Related]  

  • 9. What have positron emission tomography and 'Zippy' told us about the neuropharmacology of drug addiction?
    Cumming P; Caprioli D; Dalley JW
    Br J Pharmacol; 2011 Aug; 163(8):1586-604. PubMed ID: 20846139
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neuroimaging in drug abuse.
    Lindsey KP; Gatley SJ; Volkow ND
    Curr Psychiatry Rep; 2003 Oct; 5(5):355-61. PubMed ID: 13678555
    [TBL] [Abstract][Full Text] [Related]  

  • 11. What is the role of the D3 receptor in addiction? A mini review of PET studies with [(11)C]-(+)-PHNO.
    Payer D; Balasubramaniam G; Boileau I
    Prog Neuropsychopharmacol Biol Psychiatry; 2014 Jul; 52():4-8. PubMed ID: 23999545
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PET imaging for addiction medicine: From neural mechanisms to clinical considerations.
    Wiers CE; Cabrera E; Skarda E; Volkow ND; Wang GJ
    Prog Brain Res; 2016; 224():175-201. PubMed ID: 26822359
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Imaging addiction with PET: is insight in sight?
    Schiffer WK; Lee DE; Brodie JD; Dewey SL
    Drug Discov Today; 2005 Apr; 10(8):547-62. PubMed ID: 15837598
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Translating positron emission tomography studies in animals to stimulant addiction: promises and pitfalls.
    Caprioli D; Fryer TD; Sawiak SJ; Aigbirhio FI; Dalley JW
    Curr Opin Neurobiol; 2013 Aug; 23(4):597-606. PubMed ID: 23664005
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nonhuman primate models of addiction and PET imaging: dopamine system dysregulation.
    Gould RW; Porrino LJ; Nader MA
    Curr Top Behav Neurosci; 2012; 11():25-44. PubMed ID: 22020537
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modelling human drug abuse and addiction with dedicated small animal positron emission tomography.
    Dalley JW; Fryer TD; Aigbirhio FI; Brichard L; Richards HK; Hong YT; Baron JC; Everitt BJ; Robbins TW
    Neuropharmacology; 2009; 56 Suppl 1():9-17. PubMed ID: 18614184
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cocaine addiction: hypothesis derived from imaging studies with PET.
    Volkow ND; Ding YS; Fowler JS; Wang GJ
    J Addict Dis; 1996; 15(4):55-71. PubMed ID: 8943582
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PET imaging in clinical drug abuse research.
    Gatley SJ; Volkow ND; Wang GJ; Fowler JS; Logan J; Ding YS; Gerasimov M
    Curr Pharm Des; 2005; 11(25):3203-19. PubMed ID: 16250850
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeting the treatment of drug abuse with molecular imaging.
    Schiffer WK; Liebling CN; Patel V; Dewey SL
    Nucl Med Biol; 2007 Oct; 34(7):833-47. PubMed ID: 17921034
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human brain imaging and substance abuse.
    Lingford-Hughes A
    Curr Opin Pharmacol; 2005 Feb; 5(1):42-6. PubMed ID: 15661624
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.